U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402330) titled 'Pharmacokinetic Study of DA-020' on Feb. 02.
Brief Summary: Pharmacokinetic Study of DA-020
Study Start Date: Feb. 16
Study Type: INTERVENTIONAL
Condition:
Chemotherapy Induced Alopecia
Chemotherapy Side Effects
Intervention:
DRUG: DA-020 (0.1%)
DA-020 (0.1%)
DRUG: DA-020 (0.2%)
DA-020 (0.2%)
DRUG: DA-020 (0.5%)
DA-020 (0.5%)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Applied Biology, Inc.
Disclaimer: Curated by HT Syndication....